Ameriprise Financial, Inc.

▲ Bull Case

• ◆CT strategic review announced; disposed by FY2027: Management reveals CT disposition process; sells to a global asset manager at 10-12x earnings (CT earnings ~$700M → proceeds $7-8.4B); goodwill write-down ~$3B (non-cash; GAAP only); buyback authorization increases by $2B; P/E re-rates from 10.6x to 14-15x on pure-play AWM story; FY2028E adj. EPS $58+ × 15x = $870/share (+85%).
• ◆AWM margin reaches 35% by FY2027 + advisor count 11,000+: Technology investment compounds into advisor productivity; AUM per advisor increases from $168M to $185M; fee revenue scales; margin expansion +3pp from Q1 2026 32% = +$450M pretax = +$5/share EPS; simultaneously share count approaches 78M; FY2027E adj. EPS ~$55 × 13x = $715/share (+52%).
• ◆Equity market bull market continuation + CT inflection: S&P 500 reaches 7,500+ by FY2027 driven by AI productivity boom; AUM grows to $2.2T; AWM advisory fees reach $22B run-rate; simultaneously CT flows turn positive for first time in 3 years (narrative change); P/E re-rates to 14x; FY2027E adj. EPS $52 × 14x = $728/share (+55%).

▼ Bear Case

• ◆Equity market -20-25% recession scenario: AUM falls ~$300B from $1.73T; AWM advisory fees fall 15-20%; adj. EPS falls to $32-34; P/E compresses to 9-10x as financial services sector de-rates; stock trades to $290-340 (-28-38%). NOTE: the $2.8B buyback program at $290 = $9.7M shares/yr = 10.5% float reduction — the bear case accelerates the bull case recovery.
• ◆Columbia Threadneedle outflows accelerate to -$6-8B/quarter: Performance deterioration accelerates manager departures; institutional mandates pulled; CT earnings contribution erodes $200M+; market applies contagion risk to AWM trust; P/E further compressed to 9x; adj. EPS $38 × 9x = $342 (-27%).
• ◆Advisor attrition net negative for 2+ quarters + CT drag: Experienced advisors leaving for LPL's independent model or RIA aggregators; advisor count falls below 10,000; AUM growth decelerates to market-only appreciation; EPS growth collapses to 3-5% (no operating leverage); P/E at 10x on slower growth profile = $440 (essentially flat from current; no return above dividend + buyback).

“The central debate is whether AMP's 10.6x forward P/E (near historical floor) is a genuine discount for quality, or whether the market is correctly pricing (1) structural secular decline in active management via CT, (2) equity market beta risk, and (3) combined chair/CEO governance concerns. Bull side argues AMP's AWM business earns normalized ROE of 50-60% on economic capital — among the highest in financial services — and that the 10.6x P/E is 40% below the S&P 500 (~18x) for a business growing EPS 10-12%/yr, with a buyback yield of 6.6% alone justifying holding; CT's disposal would trigger a massive re-rating. Bear side contends AMP is cyclical with high equity market AUM correlation, that a 25% market decline would cause adj. EPS to fall 25-30% making the stock expensive in retrospect, and that LPL is winning the advisor recruitment war at scale, threatening the AWM moat. Consensus stands at 12 Buy / 4 Hold / 0 Sell with a median PT of ~$547 (16% upside); the Street is broadly bullish but acknowledges the CT overhang, with divergence primarily in CT disposal timing assumptions.”

• ◆CT strategic review announcement (2026-2027): Management discloses CT disposition process; pure-play AWM re-rating from 10-11x to 14-16x = $180-240 incremental value per share
• ◆Q2/Q3 2026 AWM pretax margin ≥33% (Aug/Oct 2026): Confirms margin expansion thesis is progressing toward management's 34-36% target
• ◆Equity market performance (ongoing): S&P 500 up 10%+; AUM hits $2T; fee revenue scales with market appreciation
• ◆Advisor count acceleration to 10,400+ by Q3 2026 (Oct 2026): Confirms AWM moat stability and growth runway
• ◆Buyback authorization refresh ≥$3B (2026): Signals continued capital return discipline; mechanical EPS accretion accelerates
• ◆Chair/CEO role separation (2026-2027): Board splits combined role; governance discount narrows; institutional investor support increases
• ◆CT quarterly net flows narrowing to <-$2B/quarter: Inflection signal reducing disposal pressure narrative and stabilizing CT multiple

• ◆Equity market -20%+ decline (20-25% probability): AUM falls ~$300B; adj. EPS falls to $32-34 (-20-27%); HIGH thesis impact as AUM-correlated business experiences fundamental impairment in recession
• ◆CT outflows accelerate >-$6B/quarter (15-20% probability): Performance deterioration drives manager departures and institutional mandate losses; -$1.5-2/share EPS; MEDIUM impact alone but damaging combined with market decline
• ◆Advisor net negative count vs. LPL competition (15-20% probability): Experienced advisors departing for independent model; AWM moat erosion signal with long-term growth deceleration consequence
• ◆CEO succession without clear named path (10-15% probability): Cracchiolo at 21 years with no disclosed successor; unexpected departure triggers multiple compression -1-2x; MEDIUM impact
• ◆Interest rate cuts reducing net interest income (20-25% probability): Fed cuts 100-150bps by FY2027 compress Ameriprise Bank NII; estimated -$0.50-1.00/share EPS; LOW-MEDIUM impact with partial AUM appreciation offset